Raul Santos: Sex Differences And Similarities in the Management of Familial Hypercholesterolemia During Life Course
Raul Santos, Researcher at ARO Hospital Israelita Albert Einstein, shared on LinkedIn:
“Delighted to share our new editorial, ‘Sex differences and similarities in the management of familial hypercholesterolemia during the life course: learning from the younglings,’ now available in Atherosclerosis. Building on the elegant study by Jan Kafol, Urh Groselj, and colleagues on sex differences in cholesterol levels among prepubertal children in Slovenia, we highlight how the genetic burden of FH can override normal physiological sex differences and why universal pediatric screening is so important.
Together with Prof. Mariko Harada-Shiba, we argue for a truly life-course and sex-sensitive approach to FH care – from early diagnosis and statin initiation in childhood, through pregnancy management, to intensifying lipid-lowering after menopause – so we can meaningfully reduce ASCVD risk for both women and men living with FH.”
Title: Sex Differences and similarities in the Management of Familial Hypercholesterolemia during life course: learning from the younglings
Authors: Mariko Harada-Shiba, Raul D. Santos
Read full study here.
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis